• Coumestrol Induces Ferroptosis in RA-FLS via PMAIP1 Modulati

  2026-04-27

  This study identifies Coumestrol, a phytoestrogen estrogen receptor antagonist, as a potent inducer of ferroptosis in fibroblast-like synoviocytes (FLS) relevant to rheumatoid arthritis (RA). By stabilizing mitochondrial PMAIP1 through inhibition of TRIM3-mediated degradation, Coumestrol suppresses FLS proliferation and inflammation, suggesting new avenues for targeted RA intervention.

• Tin Mesoporphyrin IX: Strategic Inhibition of Heme Oxygenase

  2026-04-27

  This thought-leadership article explores the mechanistic and translational impact of Tin Mesoporphyrin IX (chloride) as a potent, competitive inhibitor of heme oxygenase. Bridging metabolic, inflammatory, and virological research, we dissect the biological rationale, validate the tool’s efficacy, and offer strategic guidance for translational teams. The narrative critically integrates recent findings, highlights assay performance, and positions APExBIO’s reagent as a cornerstone for next-generation research.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-04-26

  This article reviews Wu et al.'s discovery that selective autophagy, mediated by CALCOCO2/NDP52 and regulated by deubiquitinase PSMD14, finely controls IRF3 transcription factor stability to balance type I interferon responses and immune suppression. The findings reveal mechanistic insights into immune regulation and offer methodological parallels for researchers studying transcription factor dynamics.

• Tetraethylammonium Chloride: Decoding K+ Channel Blockade in

  2026-04-25

  Explore how Tetraethylammonium chloride (TEAC) enables next-generation potassium channel research, bridging molecular blockade to functional outcomes. This article uniquely dissects practical assay design and pharmacological insight for vascular and metabolic models.

• Phosbind Acrylamide: Elevating SDS-PAGE Phosphorylation Dete

  2026-04-24

  Phosbind Acrylamide transforms protein phosphorylation analysis by enabling antibody-free, high-resolution mobility shift detection in SDS-PAGE workflows. Its selective phosphate-binding chemistry empowers researchers to dissect complex signaling cascades—such as the insulin-AMPK-PINK1 axis—without reliance on phospho-specific antibodies.

• Prochlorperazine: Dopamine D2 Antagonist in Cancer Research

  2026-04-24

  Prochlorperazine, a potent dopamine D2 receptor antagonist, has emerged as a multifaceted tool for cancer and virology research—enabling not only antiemetic therapy but also robust inhibition of melanoma cell proliferation and viral entry. This guide translates advanced mechanistic insights into clear experimental protocols, troubleshooting strategies, and practical workflow improvements, empowering researchers to maximize the utility of APExBIO’s Prochlorperazine.

• Unlocking Complex Interactions: Protein A/G Magnetic Co-IP/I

  2026-04-23

  Explore how the Protein A/G Magnetic Co-IP/IP Kit empowers advanced co-immunoprecipitation and protein-protein interaction analysis, with unique insights into neurodegenerative pathways. Discover distinct protocol guidance and evidence-based applications for translational life science research.

• EZ Cap™ Cas9 mRNA (m1Ψ): Unlocking High-Fidelity Genome Edit

  2026-04-23

  EZ Cap™ Cas9 mRNA (m1Ψ) empowers researchers with advanced mRNA features for reliable, efficient, and precise CRISPR-Cas9 genome editing in mammalian cells. Its Cap1 structure and m1Ψ modifications drive superior translation and immune evasion, while streamlined protocols and troubleshooting tips ensure robust results across diverse applications.

• LLY-507: Precision SMYD2 Inhibitor Workflows for Cancer & Fi

  2026-04-22

  LLY-507 offers unparalleled selectivity for SMYD2, enabling targeted inhibition in cancer and fibrotic disease models. This guide details optimized workflows, troubleshooting strategies, and practical insights to maximize experimental success using APExBIO’s LLY507.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-22

  Wang et al. (2024) identify a novel regulatory pathway in hepatocellular carcinoma (HCC), showing that the METTL16-SENP3-LTF axis confers resistance to ferroptosis and promotes tumorigenesis via m6A RNA modification and iron homeostasis. These insights highlight promising molecular targets for sensitizing HCC cells to ferroptosis-based therapies.

• BMN 673 (Talazoparib): Precision PARP Inhibitor for DNA Repa

  2026-04-21

  BMN 673 (Talazoparib) empowers cancer researchers with unmatched potency and selectivity for targeting homologous recombination deficient tumors. Explore robust protocols, troubleshooting insights, and next-generation applications driven by mechanistic breakthroughs in PARP1/2 inhibition.

• Tacalcitol Monohydrate: Synthetic Analog of Vitamin D3 in Re

  2026-04-21

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, enables precise modulation of gene expression in dermatological and oncology models, offering low calcemic toxicity and robust topical efficacy. This guide details experimental workflows, troubleshooting strategies, and the translational insights that distinguish it for both psoriasis and cancer research.

• SB 431542: ALK5 Inhibitor Workflows for TGF-β Pathway Resear

  2026-04-20

  SB 431542 is a benchmark ALK5 inhibitor enabling precise TGF-β pathway dissection in cell proliferation, migration, and immunology research. Leveraging recent reference studies and optimized protocols, this guide outlines advanced workflows, troubleshooting tactics, and practical applications in disease modeling.

• Ciprofloxacin Modulates RSL3-Induced Ferroptosis via Mitocho

  2026-04-20

  This study reveals an unexpected dual role for ciprofloxacin in ferroptosis regulation, enhancing RSL3-induced ferroptosis by inducing mitochondrial zinc accumulation through the STING1–CAV2 pathway. These findings expand mechanistic understanding of ferroptosis modulation and suggest new therapeutic strategies targeting zinc homeostasis in cancer cells.

• PNU 74654: Precision Wnt Signaling Pathway Inhibitor Workflo

  2026-04-19

  PNU 74654 from APExBIO delivers targeted, reproducible Wnt/β-catenin pathway inhibition for advanced cancer and stem cell research. This article details optimized workflows, troubleshooting strategies, and insights derived from recent literature on muscle progenitor biology, empowering researchers to drive impactful discoveries.

16510 records 1/1101 page Next 12345 下5页 Last page